Product image of Kalciumklorid Abboxia (Calcium) supplied by GNH India

Kalciumklorid Abboxia

Active Ingredient:
Calcium
Origin:
EU

Kalciumklorid Abboxia (Calcium)

Calcium, the active ingredient in Kalciumklorid Abboxia, is a calcium supplement presented as an intravenous solution for intravenous use. It treats calcium deficiency and hypocalcemia by rapidly restoring normal serum calcium levels in patients who require prompt correction, including those with acute or chronic calcium depletion due to postoperative states, renal impairment, or endocrine disorders.

GNH India supplies Kalciumklorid Abboxia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, manufactured under EU GMP standards and distributed through a regulated supply chain.

Manufacturer / TM Owner

Abboxia Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kalciumklorid Abboxia is used to correct calcium deficits and related metabolic disturbances, supporting essential physiological functions.

  • Calcium deficiency: restores normal serum calcium concentrations in patients with inadequate dietary intake, malabsorption syndromes, or chronic losses.
  • Hypocalcemia: rapidly raises low blood calcium levels in acute settings such as postoperative care, renal failure, or severe vitamin D deficiency.
  • Bone health maintenance: supplies calcium for bone mineralization and remodeling in individuals at risk of demineralization, such as elderly or osteoporotic patients.

How It Works

  • After intravenous administration, calcium from Kalciumklorid Abboxia dissociates into Ca2+ ions, raising extracellular calcium concentration. The increased Ca2+ supports hydroxyapatite formation for bone mineralization, facilitates muscle contraction, stabilizes neuronal membranes for nerve transmission, and participates in hormonal feedback mechanisms that regulate calcium homeostasis.

Side Effects

Intravenous calcium can be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Injection site pain: mild discomfort at the infusion site.
  • Transient hypercalcemia: temporary elevation of serum calcium that resolves without intervention.
  • Nausea: feeling of sickness or urge to vomit.

Serious or Rare Side Effects

  • Severe hypercalcemia: marked elevation of calcium causing cardiac arrhythmias.
  • Cardiac arrhythmia: irregular heart rhythm potentially life‑threatening.
  • Renal stone formation: calcium deposits in kidneys leading to obstruction.

Precautions & Warnings

When using Kalciumklorid Abboxia, several precautions should be observed to ensure safe administration.

  • Assess serum calcium: measure baseline and monitor levels during therapy to avoid overcorrection.
  • Monitor renal function: ensure kidneys can handle calcium load, especially in patients with renal impairment.
  • Avoid in hypercalcemia: contraindicated for patients with already elevated calcium concentrations.
  • Use cautiously in cardiac disease: calcium can affect myocardial contractility and conduction.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Calcium infusion may interact with several medications, requiring attention to avoid adverse effects.

Major Interactions (Avoid)

  • Digitalis glycosides: increased risk of toxicity due to calcium‑mediated effects on cardiac conduction.
  • Loop diuretics: may cause excessive calcium loss, necessitating dose adjustment.
  • Bisphosphonates: concurrent use can blunt the intended rise in serum calcium.

Moderate Interactions (Monitor Closely)

  • Thiazide diuretics: may increase calcium levels, requiring monitoring.
  • Vitamin D supplements: enhance calcium absorption, potentially leading to hypercalcemia.
  • ACE inhibitors: may affect blood pressure response during calcium infusion.

Frequently Asked Questions

Kalciumklorid Abboxia is an intravenous calcium supplement indicated for the treatment of calcium deficiency and hypocalcemia. It provides rapid restoration of serum calcium in patients who need prompt correction, such as those with postoperative, renal, or endocrine disorders.

Calcium ions act as essential cofactors in bone mineralization, muscle contraction, nerve transmission, and hormonal regulation. Intravenous calcium increases extracellular Ca2+ concentration, supporting hydroxyapatite formation in bone and stabilizing cellular excitability throughout the body.

The specific dose and infusion rate are determined by the prescribing clinician based on the patient’s serum calcium level, weight, clinical condition, and institutional protocols. No standard dose is provided here.

Safety data for intravenous calcium in pregnancy and lactation are limited. Use only if the potential benefit outweighs any possible risk, and it should be prescribed by a qualified health professional.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Compared with oral calcium salts, the intravenous form provides an immediate increase in serum calcium, which is advantageous in acute hypocalcemia. Unlike some calcium gluconate preparations, the formulation and concentration may differ, so clinicians select based on the required calcium load and compatibility with other IV drugs.

The solution should be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the vial. Before use, allow the product to reach room temperature if required and inspect for particulate matter.

Kalciumklorid Abboxia is given by slow intravenous infusion, typically diluted in compatible IV fluids as directed by the prescribing clinician. Administration should be performed by trained healthcare personnel under appropriate monitoring.

The most critical adverse events include severe hypercalcemia, cardiac arrhythmias, and renal stone formation. Prompt recognition of symptoms such as chest pain, palpitations, sudden drop in blood pressure, or flank pain is essential, and immediate medical intervention may be required.

Patients with existing hypercalcemia, severe renal impairment, known hypersensitivity to calcium preparations, or those receiving medications that contraindicate calcium infusion (e.g., certain digitalis therapies) should avoid this product unless a clinician determines it is safe.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Calcium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT